Skip to content
akaturk Academic measurement
Sign in Register

OpenAlex topic

Urinary Bladder and Prostate Research

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 5,590 works 331 author topics

Works

5,590 works

  1. Reasons for early readmission after percutaneous nephrolithotomy and retrograde intrarenal surgery 2019
    YÖKSİS SJR Q3 JCR Q4 OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: Darolutamide is a structurally unique androgen-receptor antagonist that is under development for the treatment of prostate cancer. We evaluated the efficacy of darolutamide for delaying metastasis and death in men with nonmetastatic, castration-resistant prostate cancer. METHODS: We conducted a randomized,…

  2. Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer 2019
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: Darolutamide is a structurally unique androgen-receptor antagonist that is under development for the treatment of prostate cancer. We evaluated the efficacy of darolutamide for delaying metastasis and death in men with nonmetastatic, castration-resistant prostate cancer. METHODS: We conducted a randomized,…

  3. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update 2014
    OpenAlex top 1% OpenAlex 100.0%

    No abstract yet.

  4. EAU 2004 Guidelines on Assessment, Therapy and Follow-Up of Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction (BPH Guidelines) 2004
    OpenAlex top 1% OpenAlex 99.8%

    No abstract yet.

  5. An Evidence-Based Unified Definition of Lifelong and Acquired Premature Ejaculation: Report of the Second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation 2014
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%

    INTRODUCTION: The International Society for Sexual Medicine (ISSM) Ad Hoc Committee for the Definition of Premature Ejaculation developed the first evidence-based definition for lifelong premature ejaculation (PE) in 2007 and concluded that there were insufficient published objective data at that time to develop a def…

  6. EAU Guidelines on Benign Prostatic Hyperplasia (BPH) 2001
    OpenAlex top 1% OpenAlex 99.1%

    No abstract yet.

  7. The Urinary Tract Microbiome in Health and Disease 2016
    OpenAlex top 10% OpenAlex 98.1%

    No abstract yet.

  8. The International Continence Society "Benign Prostatic Hyperplasia" Study: the botherosomeness of urinary symptoms. 1997
    OpenAlex top 10% OpenAlex 98.7%

    PURPOSE: We assessed the bothersomeness of lower urinary tract symptoms as reported by men, and investigated relationships among occurrence, degree of problem caused and age. MATERIALS AND METHODS: Questionnaire data from 1,271 men presenting with lower urinary tract symptoms in 12 countries were analyzed. Statistical…

  9. Bipolar versus Monopolar Transurethral Resection of the Prostate: A Systematic Review and Meta-analysis of Randomized Controlled Trials 2009
    OpenAlex top 1% OpenAlex 100.0%

    No abstract yet.

  10. An Evidence-Based Unified Definition of Lifelong and Acquired Premature Ejaculation: Report of the Second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation 2014
    OpenAlex top 10% OpenAlex 98.8%

    Abstract Introduction The International Society for Sexual Medicine (ISSM) Ad Hoc Committee for the Definition of Premature Ejaculation developed the first evidence-based definition for lifelong premature ejaculation (PE) in 2007 and concluded that there were insufficient published objective data at that time to devel…

  11. Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men 2012
    OpenAlex top 1% OpenAlex 99.7%

    PURPOSE: The 6th International Consultation on New Developments in Prostate Cancer and Prostate Diseases met from June 24-28, 2005 in Paris, France to review new developments in benign prostatic disease. MATERIALS AND METHODS: A series of committees were asked to produce recommendations on the evaluation and treatment…

  12. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 2022
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 100.0%

    BACKGROUND: Benign prostatic hyperplasia is a common urological disease affecting older men worldwide, but comprehensive data about the global, regional, and national burden of benign prostatic hyperplasia and its trends over time are scarce. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (…

Academicians

331 academicians